Hammonton, NJ
Joined December 2017
#Daraxonrasib @RevMedicines, widely expected to have transformational impact on #PancreaticCancer treatment, now shows an "encouraging signal" in #LungCancer. Thanks to @KCArbourMD @MSKCancerCenter for sharing insights! @NEJM
🫁 #Daraxonrasib, recently approved for #PancreaticCancer, induces durable responses in metastatic #LungCancer. @KCArbourMD @MSKCancerCenter shares insights into the “very encouraging signal” 👇 vist.ly/5h6nm
2
95
Thank you to Dr. Anna Herby @PCRM for sharing expert insights into a national initiative inviting hospitals to serve more nutritious meals & how everyone who works in #HealthCare can help empower patients to take control of their health.
🏥 U.S. hospitals have been asked to sign a pledge to make the food they serve healthier. Among the goals: 🥓 Limit processed meats 🍎 Emphasize fruits & vegetables 🍟 Skip deep frying in favor of other prep methods 🥤 Limit sugar-sweetened beverages vist.ly/5aita
3
247
#ASCO26 is in the books, but don’t worry... @GoHealio @HemOncToday coverage of groundbreaking #cancer research continues! Catch the latest data & expert perspective on #AI, #GLP1, #immunotherapy and more here: bit.ly/4u7i1NR Until next year, #Chicago!
4
183
Dr. Brian Wolpin @DanaFarber on #daraxonrasib #PancreaticCancer data he presented at #ASCO26: 'I find myself thinking about the large number of patients I have taken care of [and] all of those people who have passed away. ... They deserve this.' Story 👇 bit.ly/3QcOaFX
5
22
1,734
Always great to connect with @ShepardDale @ClevelandClinic @CleClinicMD Thank you very much for sharing your insights on important #sarcoma research presented at #ASCO26!
1
99
It’s Day 2 of #ASCO26. Another beautiful morning to enjoy some fresh air and a great view before today’s press briefing and abstract sessions get underway.
1
1
1
66
Thank you to Dr. Hans C. Lee @SarahCannonDocs for sharing insights into the 'unprecedented' results with #linvoseltamab in relapsed or refractory systemic light chain #amyloidosis. #ASCO26
3
168
Day 1 of #ASCO26 is in full swing. I had the privilege of speaking with Dr. Mary-Ellen Taplin @DanaFarber @DanaFarber_GU about the PROTEUS trial. Stay tuned to @GoHealio & @HemOncToday for the full story later this weekend. #ProstateCancer
1
92
Hello, #ASCO26! The @GoHealio @HemOncToday team is thrilled to be back and excited to provide live coverage of this year's meeting. Stay up to date with the big news and expert perspective here: bit.ly/4wYOit2
2
3
164
Thank you to @JenniferLitton @MDAndersonnews and Emma A. Meagher, MD, @PennMedicine for providing great insights into how @US_FDA's real-time #ClinicalTrials initiative may accelerate the pace at which new treatments become available to patients.
1
52
Thank you to @nievamd @uscnorris for sharing insights into fascinating #AACR26 data. Could residue from pesticides be driving the 'hidden' #LungCancer epidemic among young nonsmokers? Find out here 👇
1
1
141
Expert perspective: Phase 3 data show 'striking' benefit with #daraxonrasib vs. chemotherapy for #PancreaticCancer. "Although the data warrant careful scrutiny, they inspire optimism," @laleh_melstrom @CityofHopeSurg @cityofhope tells @GoHealio. Read more 👇
111
🤝Today, @HemOncToday is teaming up with @HealioGastro for #DressInBlueDay 💙 From screening to treatment, #ColorectalCancer is a team sport, and we’ve got the latest plays covered ➡️ bit.ly/4l8KdwS #ColorectalCancerAwareness
4
10
213
#ColorectalCancer incidence in the US declined since 2013, but cases are ⬆️ among younger Americans. @rlsiegel25 @ACSNews tells @GoHealio it is time to break the 'taboo' by normalizing conversations about symptoms, screening & family history 👇
3
86
‘Words matter’ Using ‘provider’ to describe physicians is dehumanizing & does not reflect the profession, @ACPIMPhysicians president @jasongoldmanmd tells @GoHealio. Read more about ACP's new position paper 👇
3
69
What can cancer centers and other institutions do to ensure scientifically accurate information reaches & resonates with diverse populations, including those with different political ideologies? Dr. Christopher W. Wheldon @TempleCPH explains.
🏛️ Americans’ trust in scientists for #cancer information may vary by political ideology. 🎙️ Hear Dr. Christopher W. Wheldon @TempleCPH discuss the need to frame messaging to ensure scientifically accurate information resonates with the public. bit.ly/4a3LVMt
1
22